Skip to main content
Erschienen in: Journal of Neurology 3/2015

01.03.2015 | Original Communication

Familial Creutzfeldt–Jakob disease with the E200K mutation: longitudinal neuroimaging from asymptomatic to symptomatic CJD

verfasst von: Oren S. Cohen, Joab Chapman, Amos D. Korczyn, Zeev Nitsan, Shmuel Appel, Chen Hoffmann, Hanna Rosenmann, Esther Kahana, Hedok Lee

Erschienen in: Journal of Neurology | Ausgabe 3/2015

Einloggen, um Zugang zu erhalten

Abstract

Familial Creutzfeldt–Jakob disease (fCJD) in Jews of Libyan ancestry is caused by an E200K mutation in the PRNP gene. While carriers are born with this mutation, they usually remain asymptomatic until middle age. Early detection of conversion is crucial for understanding and eventually for the treatment of the disease. The aim of this study was to report longitudinal MRI data in E200K individuals who eventually converted from healthy mutation carriers to clinically symptomatic CJD. As a part of a prospective study, asymptomatic E200K mutation carriers were scanned annually until their conversion to symptomatic disease. Standardized diffusion and anatomical MR sequences were performed before and after clinical conversion in the subjects and those were compared to 15 non-carrier siblings (“healthy controls”). Blinded radiological readings and region of interest analyses were performed. Radiological readings of individual cases failed to detect characteristic changes in the scans taken before the conversion. Region of interest analysis of diffusion changes in pre-symptomatic stage was inconclusive; however, ADC reduction was found in early and late stages of the disease. Computerized volumetric analysis revealed monotonic volume reductions in thalamus, putamen and caudate following conversion, and the lateral ventricles showed dilatation of up to 62 % after clinical conversion. Although the clinical manifestations at disease onset are variable, the diffusion abnormalities and/or volume changes in the thalamus and basal ganglia during conversion may indicate early involvement of the thalamostriatal neuronal circuit.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
3.
Zurück zum Zitat Korczyn AD (1991) Creutzfeldt–Jakob disease among Libyan Jews. Eur J Epidemiol 7:490–4933CrossRefPubMed Korczyn AD (1991) Creutzfeldt–Jakob disease among Libyan Jews. Eur J Epidemiol 7:490–4933CrossRefPubMed
4.
Zurück zum Zitat Goldfarb LG, Korczyn AD, Brown P, Chapman J, Gajdusek DC (1990) Mutation in codon 200 of scrapie amyloid precursor gene linked to Creutzfeldt–Jakob disease in Sephardic Jews of Libyan and non-Libyan origin. Lancet 336:637–638CrossRefPubMed Goldfarb LG, Korczyn AD, Brown P, Chapman J, Gajdusek DC (1990) Mutation in codon 200 of scrapie amyloid precursor gene linked to Creutzfeldt–Jakob disease in Sephardic Jews of Libyan and non-Libyan origin. Lancet 336:637–638CrossRefPubMed
5.
Zurück zum Zitat Hsiao K, Meiner Z, Kahana E, Cass C, Kahana I, Avrahami D, Scarlato G, Abramsky O, Prusiner SB, Gabizon R (1991) Mutation of the prion protein in Libyan Jews with Creutzfeldt–Jakob disease. N Engl J Med 324:1091–1097CrossRefPubMed Hsiao K, Meiner Z, Kahana E, Cass C, Kahana I, Avrahami D, Scarlato G, Abramsky O, Prusiner SB, Gabizon R (1991) Mutation of the prion protein in Libyan Jews with Creutzfeldt–Jakob disease. N Engl J Med 324:1091–1097CrossRefPubMed
6.
Zurück zum Zitat Chapman J, Ben-Israel J, Goldhammer Y, Korczyn AD (1994) The risk of developing Creutzfeldt–Jakob disease in subjects with the PRNP gene codon 200 point mutation. Neurology 44:1683–1686CrossRefPubMed Chapman J, Ben-Israel J, Goldhammer Y, Korczyn AD (1994) The risk of developing Creutzfeldt–Jakob disease in subjects with the PRNP gene codon 200 point mutation. Neurology 44:1683–1686CrossRefPubMed
7.
Zurück zum Zitat Rosenmann H, Talmor G, Halimi M, Yanai A, Gabizon R, Meiner Z (2001) Prion protein with an E200K mutation displays properties similar to those of the cellular isoform PrP(C). J Neurochem 76:1654–1662CrossRefPubMed Rosenmann H, Talmor G, Halimi M, Yanai A, Gabizon R, Meiner Z (2001) Prion protein with an E200K mutation displays properties similar to those of the cellular isoform PrP(C). J Neurochem 76:1654–1662CrossRefPubMed
8.
Zurück zum Zitat Young GS, Geschwind MD, Fischbein NJ, Martindale JL, Henry RG, Liu S, Lu Y, Wong S, Liu H, Miller BL, Dillon WP (2005) Diffusion-weighted and fluid-attenuated inversion recovery imaging in Creutzfeldt–Jakob disease: high sensitivity and specificity for diagnosis. Am J Neuroradiol 26:1551–1562PubMed Young GS, Geschwind MD, Fischbein NJ, Martindale JL, Henry RG, Liu S, Lu Y, Wong S, Liu H, Miller BL, Dillon WP (2005) Diffusion-weighted and fluid-attenuated inversion recovery imaging in Creutzfeldt–Jakob disease: high sensitivity and specificity for diagnosis. Am J Neuroradiol 26:1551–1562PubMed
9.
Zurück zum Zitat Fulbright RK, Kingsley PB, Guo X, Hoffmann C, Kahana E, Chapman JC, Prohovnik I (2006) The imaging appearance of Creutzfeldt–Jakob disease caused by the E200K mutation. Magn Reson Imaging 24:1121–1129CrossRefPubMed Fulbright RK, Kingsley PB, Guo X, Hoffmann C, Kahana E, Chapman JC, Prohovnik I (2006) The imaging appearance of Creutzfeldt–Jakob disease caused by the E200K mutation. Magn Reson Imaging 24:1121–1129CrossRefPubMed
10.
Zurück zum Zitat Fulbright RK, Hoffmann C, Lee H, Pozamantir A, Chapman J, Prohovnik I (2008) MR imaging of familial Creutzfeldt–Jakob disease: a blinded and controlled study. AJNR Am J Neuroradiol 29:1638–1643CrossRefPubMed Fulbright RK, Hoffmann C, Lee H, Pozamantir A, Chapman J, Prohovnik I (2008) MR imaging of familial Creutzfeldt–Jakob disease: a blinded and controlled study. AJNR Am J Neuroradiol 29:1638–1643CrossRefPubMed
11.
Zurück zum Zitat Kono S, Manabe Y, Fuji D, Sakai Y, Narai H, Omori N, Kitamoto T, Abe K (2011) Serial diffusion-weighted MRI and SPECT findings in a Creutzfeldt–Jakob disease patient with V180I mutation. J Neurol Sci 301:100–103CrossRefPubMed Kono S, Manabe Y, Fuji D, Sakai Y, Narai H, Omori N, Kitamoto T, Abe K (2011) Serial diffusion-weighted MRI and SPECT findings in a Creutzfeldt–Jakob disease patient with V180I mutation. J Neurol Sci 301:100–103CrossRefPubMed
12.
Zurück zum Zitat Terasawa Y, Fujita K, Izumi Y, Kaji R (2012) Early detection of familial Creutzfeldt–Jakob disease on diffusion-weighted imaging before symptom onset. J Neurol Sci 319:130–132CrossRefPubMed Terasawa Y, Fujita K, Izumi Y, Kaji R (2012) Early detection of familial Creutzfeldt–Jakob disease on diffusion-weighted imaging before symptom onset. J Neurol Sci 319:130–132CrossRefPubMed
13.
Zurück zum Zitat Lee H, Rosenmann H, Chapman J, Kingsley PB, Hoffmann C, Cohen OS, Kahana E, Korczyn AD, Prohovnik I (2009) Thalamo-striatal diffusion reductions precede disease onset in prion mutation carriers. Brain 132:2680–2687PubMedCentralCrossRefPubMed Lee H, Rosenmann H, Chapman J, Kingsley PB, Hoffmann C, Cohen OS, Kahana E, Korczyn AD, Prohovnik I (2009) Thalamo-striatal diffusion reductions precede disease onset in prion mutation carriers. Brain 132:2680–2687PubMedCentralCrossRefPubMed
14.
Zurück zum Zitat Meissner B, Kallenberg K, Sanchez-Juan P, Collie D, Summers DM, Almonti S, Zerr I (2009) MRI lesion profiles in sporadic Creutzfeldt–Jakob disease. Neurology 72:1994–2001CrossRefPubMed Meissner B, Kallenberg K, Sanchez-Juan P, Collie D, Summers DM, Almonti S, Zerr I (2009) MRI lesion profiles in sporadic Creutzfeldt–Jakob disease. Neurology 72:1994–2001CrossRefPubMed
15.
Zurück zum Zitat Caverzasi E, Henry RG, Vitali P, Lobach IV, Kornak J, Bastianello S, Dearmond SJ, Miller BL, Rosen HJ, Mandelli ML, Geschwind MD (2014) Application of quantitative DTI metrics in sporadic CJD. Neuroimage Clin 4:426–435PubMedCentralCrossRefPubMed Caverzasi E, Henry RG, Vitali P, Lobach IV, Kornak J, Bastianello S, Dearmond SJ, Miller BL, Rosen HJ, Mandelli ML, Geschwind MD (2014) Application of quantitative DTI metrics in sporadic CJD. Neuroimage Clin 4:426–435PubMedCentralCrossRefPubMed
16.
Zurück zum Zitat Vitali P, Maccagnano E, Caverzasi E, Henry RG, Haman A, Torres-Chae C, Johnson DY, Miller BL, Geschwind MD (2011) Diffusion-weighted MRI hyper intensity patterns differentiate CJD from other rapid dementias. Neurology 76:1711–1719PubMedCentralCrossRefPubMed Vitali P, Maccagnano E, Caverzasi E, Henry RG, Haman A, Torres-Chae C, Johnson DY, Miller BL, Geschwind MD (2011) Diffusion-weighted MRI hyper intensity patterns differentiate CJD from other rapid dementias. Neurology 76:1711–1719PubMedCentralCrossRefPubMed
17.
Zurück zum Zitat Folstein MF, Folstein SE, McHugh PR (1975) Mini-mental state. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189–198CrossRefPubMed Folstein MF, Folstein SE, McHugh PR (1975) Mini-mental state. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189–198CrossRefPubMed
18.
Zurück zum Zitat Cohen OS, Prohovnik I, Korczyn AD, Ephraty L, Nitsan Z, Tsabari R, Appel S, The Creutzfeldt–Jakob disease (CJD), Rosenmann H, Kahana E, Chapman J (2011) Neurological status scale: a new tool for evaluation of disease severity and progression in CJD. Acta Neurol Scand 124:368–374 Cohen OS, Prohovnik I, Korczyn AD, Ephraty L, Nitsan Z, Tsabari R, Appel S, The Creutzfeldt–Jakob disease (CJD), Rosenmann H, Kahana E, Chapman J (2011) Neurological status scale: a new tool for evaluation of disease severity and progression in CJD. Acta Neurol Scand 124:368–374
19.
Zurück zum Zitat Kurtzke JF (1983) Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33:1444–1452CrossRefPubMed Kurtzke JF (1983) Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33:1444–1452CrossRefPubMed
20.
Zurück zum Zitat Dubois B, Slachevsky A, Litvan I, Pillon B (2000) The FAB: a frontal assessment battery at bedside. Neurology 55:1621–1626CrossRefPubMed Dubois B, Slachevsky A, Litvan I, Pillon B (2000) The FAB: a frontal assessment battery at bedside. Neurology 55:1621–1626CrossRefPubMed
21.
Zurück zum Zitat Lyden P, Brott T, Tilley B, Welch KM, Mascha EJ, Levine S, Haley EC, Grotta J, Marler J (1994) Improved reliability of the NIH Stroke Scale using video training, NINDS TPA Stroke Study Group. Stroke 25:2220–2226CrossRefPubMed Lyden P, Brott T, Tilley B, Welch KM, Mascha EJ, Levine S, Haley EC, Grotta J, Marler J (1994) Improved reliability of the NIH Stroke Scale using video training, NINDS TPA Stroke Study Group. Stroke 25:2220–2226CrossRefPubMed
22.
Zurück zum Zitat WHO Global Surveillance, diagnosis and therapy of human transmissible Spongiform encephalopathies: report of the WHO consultation (1998) In: Proceedings of World Health Organization: emerging and other communicable diseases, surveillance and control 9–11 Feb; Geneva WHO Global Surveillance, diagnosis and therapy of human transmissible Spongiform encephalopathies: report of the WHO consultation (1998) In: Proceedings of World Health Organization: emerging and other communicable diseases, surveillance and control 9–11 Feb; Geneva
23.
Zurück zum Zitat Stejskal E, Tanner J (1965) Spin diffusion measurements: spin echoes in the presence of a time-dependent field gradient. J Chem Phys 42:288–292CrossRef Stejskal E, Tanner J (1965) Spin diffusion measurements: spin echoes in the presence of a time-dependent field gradient. J Chem Phys 42:288–292CrossRef
24.
Zurück zum Zitat Seror I, Lee H, Cohen OS, Hoffmann C, Prohovnik I (2010) Putaminal volume and diffusion in early familial Creutzfeldt–Jakob disease. J Neurol Sci 288:129–134PubMedCentralCrossRefPubMed Seror I, Lee H, Cohen OS, Hoffmann C, Prohovnik I (2010) Putaminal volume and diffusion in early familial Creutzfeldt–Jakob disease. J Neurol Sci 288:129–134PubMedCentralCrossRefPubMed
25.
Zurück zum Zitat Patenaude B, Smith SM, Kennedy D, Jenkinson M (2011) A Bayesian model of shape and appearance for subcortical brain segmentation. Neuroimage 56:907–922 Patenaude B, Smith SM, Kennedy D, Jenkinson M (2011) A Bayesian model of shape and appearance for subcortical brain segmentation. Neuroimage 56:907–922
26.
Zurück zum Zitat Lee H, Hoffman C, Kingsley PB, Degnan A, Cohen O, Prohovnik I (2010) Enhanced detection of diffusion reductions in Creutzfeldt–Jakob disease at a higher B factor. Am J Neuroradiol 31:49–54CrossRefPubMed Lee H, Hoffman C, Kingsley PB, Degnan A, Cohen O, Prohovnik I (2010) Enhanced detection of diffusion reductions in Creutzfeldt–Jakob disease at a higher B factor. Am J Neuroradiol 31:49–54CrossRefPubMed
27.
Zurück zum Zitat Tschampa HJ, Mürtz P, Flacke S, Paus S, Schild HH, Urbach H (2003) Thalamic involvement in sporadic Creutzfeldt–Jakob disease: a diffusion-weighted MR imaging study. Am J Neuroradiol 24:908–915PubMed Tschampa HJ, Mürtz P, Flacke S, Paus S, Schild HH, Urbach H (2003) Thalamic involvement in sporadic Creutzfeldt–Jakob disease: a diffusion-weighted MR imaging study. Am J Neuroradiol 24:908–915PubMed
28.
Zurück zum Zitat Chapman J, Brown P, Goldfarb LG, Arlazoroff A, Gajdusek DC, Korczyn AD (1993) Clinical heterogeneity and unusual presentations of Creutzfeldt–Jakob disease in Jewish patients with the PRNP codon 200 mutation. J Neurol Neurosurg Psychiatry 56:1109–1112PubMedCentralCrossRefPubMed Chapman J, Brown P, Goldfarb LG, Arlazoroff A, Gajdusek DC, Korczyn AD (1993) Clinical heterogeneity and unusual presentations of Creutzfeldt–Jakob disease in Jewish patients with the PRNP codon 200 mutation. J Neurol Neurosurg Psychiatry 56:1109–1112PubMedCentralCrossRefPubMed
29.
Zurück zum Zitat Givaty G, Shechter-Amir D, Cohen O, Blatt I, Prohovnik I, Chapman J (2009) Early pathology in sleep studies of patients with familial Creutzfeldt–Jakob disease. Neurology 72(suppl.3):A433 Givaty G, Shechter-Amir D, Cohen O, Blatt I, Prohovnik I, Chapman J (2009) Early pathology in sleep studies of patients with familial Creutzfeldt–Jakob disease. Neurology 72(suppl.3):A433
30.
Zurück zum Zitat Cohen OS, Prohovnik I, Korczyn AD, Inzelberg R, Nitsan Z, Appel S, Kahana E, Rosenmann H, Chapman J (2012) Characterization of movement disorders in patients with familial Creutzfeldt–Jakob disease (f-CJD) carrying the E200K mutation. Isr J Med Assoc (IMAJ) 14:3162–3165 Cohen OS, Prohovnik I, Korczyn AD, Inzelberg R, Nitsan Z, Appel S, Kahana E, Rosenmann H, Chapman J (2012) Characterization of movement disorders in patients with familial Creutzfeldt–Jakob disease (f-CJD) carrying the E200K mutation. Isr J Med Assoc (IMAJ) 14:3162–3165
31.
Zurück zum Zitat Breithaupt M, Romero C, Kallenberg K, Begue C, Sanchez-Juan P, Eigenbrod S, Kretzschmar H, Schelzke G, Meichtry E, Taratuto A, Zerr I (2013) Magnetic resonance imaging in E200K and V210I mutations of the prion protein gene. Alzheimer Dis Assoc Disord 7:87–90CrossRef Breithaupt M, Romero C, Kallenberg K, Begue C, Sanchez-Juan P, Eigenbrod S, Kretzschmar H, Schelzke G, Meichtry E, Taratuto A, Zerr I (2013) Magnetic resonance imaging in E200K and V210I mutations of the prion protein gene. Alzheimer Dis Assoc Disord 7:87–90CrossRef
32.
Zurück zum Zitat Shiga Y, Miyazawa K, Sato S, Fukushima R, Shibuya S, Sato Y, Konno H, Doh-ura K, Mugikura S, Tamura H, Higano S, Takahashi S, Itoyama Y (2004) Diffusion-weighted MRI abnormalities as an early diagnostic marker for Creutzfeldt–Jakob disease. Neurology 63:443–449CrossRefPubMed Shiga Y, Miyazawa K, Sato S, Fukushima R, Shibuya S, Sato Y, Konno H, Doh-ura K, Mugikura S, Tamura H, Higano S, Takahashi S, Itoyama Y (2004) Diffusion-weighted MRI abnormalities as an early diagnostic marker for Creutzfeldt–Jakob disease. Neurology 63:443–449CrossRefPubMed
33.
Zurück zum Zitat Zerr I, Kallenberg K, Summers DM, Romero C, Taratuto A, Heinemann U, Breithaupt M, Varges D, Meissner B, Ladogana A, Schuur M, Haik S, Collins SJ, Jansen GH, Stokin GB, Pimentel J, Hewer E, Collie D, Smith P, Roberts H, Brandel JP, van Duijn C, Pocchiari M, Begue C, Cras P, Will RG, Sanchez-Juan P (2009) Updated clinical diagnostic criteria for sporadic Creutzfeldt–Jakob disease. Brain 132:2659–2668PubMedCentralCrossRefPubMed Zerr I, Kallenberg K, Summers DM, Romero C, Taratuto A, Heinemann U, Breithaupt M, Varges D, Meissner B, Ladogana A, Schuur M, Haik S, Collins SJ, Jansen GH, Stokin GB, Pimentel J, Hewer E, Collie D, Smith P, Roberts H, Brandel JP, van Duijn C, Pocchiari M, Begue C, Cras P, Will RG, Sanchez-Juan P (2009) Updated clinical diagnostic criteria for sporadic Creutzfeldt–Jakob disease. Brain 132:2659–2668PubMedCentralCrossRefPubMed
Metadaten
Titel
Familial Creutzfeldt–Jakob disease with the E200K mutation: longitudinal neuroimaging from asymptomatic to symptomatic CJD
verfasst von
Oren S. Cohen
Joab Chapman
Amos D. Korczyn
Zeev Nitsan
Shmuel Appel
Chen Hoffmann
Hanna Rosenmann
Esther Kahana
Hedok Lee
Publikationsdatum
01.03.2015
Verlag
Springer Berlin Heidelberg
Erschienen in
Journal of Neurology / Ausgabe 3/2015
Print ISSN: 0340-5354
Elektronische ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-014-7615-1

Weitere Artikel der Ausgabe 3/2015

Journal of Neurology 3/2015 Zur Ausgabe

Pioneers in Neurology

Max Bielschowsky (1869–1940)

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.